Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Lloyd Clark

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Ophthalmology. Retina|August 29, 2024
Interim Results of the Phase III Portal Extension Trial of the Port Delivery System with Ranibizumab in Neovascular Age-Related Macular DegenerationPeter A Campochiaro, David Eichenbaum, Margaret A Chang, et al.
Ophthalmology|April 1, 2014
Intravitreal aflibercept injection for macular edema due to central retinal vein occlusion: two-year results from the COPERNICUS studyJeffrey S Heier, W Lloyd Clark, David S Boyer, et al.
Ophthalmology. Retina|October 18, 2024
Longitudinal Changes in Diabetic Retinopathy Severity: Learnings from PANORAMACharles C Wykoff, Diana V Do, W Lloyd Clark, et al.
Ophthalmology|October 4, 2016
Intravitreal Sirolimus for Noninfectious Uveitis: A Phase III Sirolimus Study Assessing Double-masKed Uveitis TReAtment (SAKURA)Quan Dong Nguyen, Pauline T Merrill, W Lloyd Clark, et al.
Clinical Ophthalmology (Auckland, N.Z.)|September 9, 2017
Integrated results from the COPERNICUS and GALILEO studiesAmelie Pielen, W Lloyd Clark, David S Boyer, et al.
Ophthalmology|November 3, 2015
Intravitreal Aflibercept for Macular Edema Following Branch Retinal Vein Occlusion: 52-Week Results of the VIBRANT StudyW Lloyd Clark, David S Boyer, Jeffrey S Heier, et al.
Ophthalmology|October 16, 2014
Intravitreal aflibercept for macular edema following branch retinal vein occlusion: the 24-week results of the VIBRANT studyPeter A Campochiaro, W Lloyd Clark, David S Boyer, et al.
Ophthalmology. Retina|November 4, 2024
Ocular and Systemic Risk Factors for Disease Worsening Among Patients with NPDR: Post Hoc Analysis of the PANORAMA TrialCharles C Wykoff, Diana V Do, Roger A Goldberg, et al.
Ophthalmology|September 25, 2016
ReplyW Lloyd Clark, David S Boyer, Jeffrey S Heier, et al.
American Journal of Ophthalmology|July 15, 2023
Exudation in Patients With Neovascular Age-Related Macular Degeneration Treated With the Port Delivery System or Monthly InjectionsAnam Akhlaq, David Williams, W Lloyd Clark, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Ophthalmology. Retina|August 29, 2024
Interim Results of the Phase III Portal Extension Trial of the Port Delivery System with Ranibizumab in Neovascular Age-Related Macular DegenerationPeter A Campochiaro, David Eichenbaum, Margaret A Chang, et al.
Ophthalmology|April 1, 2014
Intravitreal aflibercept injection for macular edema due to central retinal vein occlusion: two-year results from the COPERNICUS studyJeffrey S Heier, W Lloyd Clark, David S Boyer, et al.
Ophthalmology. Retina|October 18, 2024
Longitudinal Changes in Diabetic Retinopathy Severity: Learnings from PANORAMACharles C Wykoff, Diana V Do, W Lloyd Clark, et al.
Ophthalmology|October 4, 2016
Intravitreal Sirolimus for Noninfectious Uveitis: A Phase III Sirolimus Study Assessing Double-masKed Uveitis TReAtment (SAKURA)Quan Dong Nguyen, Pauline T Merrill, W Lloyd Clark, et al.
Clinical Ophthalmology (Auckland, N.Z.)|September 9, 2017
Integrated results from the COPERNICUS and GALILEO studiesAmelie Pielen, W Lloyd Clark, David S Boyer, et al.
Ophthalmology|November 3, 2015
Intravitreal Aflibercept for Macular Edema Following Branch Retinal Vein Occlusion: 52-Week Results of the VIBRANT StudyW Lloyd Clark, David S Boyer, Jeffrey S Heier, et al.
Ophthalmology|October 16, 2014
Intravitreal aflibercept for macular edema following branch retinal vein occlusion: the 24-week results of the VIBRANT studyPeter A Campochiaro, W Lloyd Clark, David S Boyer, et al.
Ophthalmology. Retina|November 4, 2024
Ocular and Systemic Risk Factors for Disease Worsening Among Patients with NPDR: Post Hoc Analysis of the PANORAMA TrialCharles C Wykoff, Diana V Do, Roger A Goldberg, et al.
Ophthalmology|September 25, 2016
ReplyW Lloyd Clark, David S Boyer, Jeffrey S Heier, et al.
American Journal of Ophthalmology|July 15, 2023
Exudation in Patients With Neovascular Age-Related Macular Degeneration Treated With the Port Delivery System or Monthly InjectionsAnam Akhlaq, David Williams, W Lloyd Clark, et al.
Pageof 4